Ambagon Therapeutics Launches With $85 Million Series A to Advance Pioneering Molecular Glue Platform and Progress Pipeline; Modular platform enables development of molecular glue stabilizers addressing intrinsically disordered proteins, a largely undrugg

Media coverage

• Title	Ambagon Therapeutics Launches With $85 Million Series A to Advance Pioneering Molecular Glue Platform and Progress Pipeline; Modular platform enables development of molecular glue stabilizers addressing intrinsically disordered proteins, a largely undrugg
  Media name/outlet	Business Wire
  Country/Territory	United States
  Date	6/01/22
  Persons	Luc Brunsveld, Christian Ottmann